Lanean...
Lessons from gefitinib-induced interstitial lung disease in Japan: Problems in approval, pharmacovigilance, and regulatory decision-making procedures
Objective: The objective of this study was to identifyproblems in the approval, pharmacovigilance, andpost-approval regulatory decision-makingprocedures involving gefitinib and to proposecountermeasures to prevent further drug-inducedsuffering in Japan in the future.Methods: We comprehensively revie...
Gorde:
| Argitaratua izan da: | Pharmacy Practice |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Centro de investigaciones y Publicaciones Farmacéuticas
2006
|
| Gaiak: | |
| Sarrera elektronikoa: | https://www.redalyc.org/articulo.oa?id=69040404 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|